scholarly article | Q13442814 |
P356 | DOI | 10.3389/FNAGI.2022.804937 |
P2093 | author name string | Muzaffer Kaser | |
Arka Saha | |||
Lucy G. Cheke | |||
Ruby Liu | |||
Mark P. Haggard | |||
Alvaro Benito Ballesteros | |||
Lyn Curtis | |||
Panyuan Guo | |||
Sabine P. Yeung | |||
P2860 | cites work | The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning | Q104746179 |
Attributes and predictors of long COVID | Q106368743 | ||
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” | Q108834025 | ||
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19 | Q110295363 | ||
Characteristics and impact of Long Covid: Findings from an online survey | Q112280849 | ||
Association between acute care and critical illness hospitalization and cognitive function in older adults | Q24602638 | ||
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis | Q24628579 | ||
From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity | Q24634258 | ||
Role of neuroinflammation in neurodegenerative diseases (Review) | Q28080292 | ||
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis | Q29619037 | ||
Inflammation is detrimental for neurogenesis in adult brain | Q29619040 | ||
Post-stroke dementia - a comprehensive review | Q31155081 | ||
Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? | Q33492926 | ||
Cytokine targets in the brain: impact on neurotransmitters and neurocircuits | Q34078917 | ||
Lateralization of olfactory processes | Q34356079 | ||
Long-term cognitive impairment after critical illness | Q34374900 | ||
Six-month neuropsychological outcome of medical intensive care unit patients | Q35102021 | ||
Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. | Q36802488 | ||
Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults | Q36925067 | ||
Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study | Q37010556 | ||
Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. | Q37459522 | ||
Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? | Q37533353 | ||
Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy | Q37671461 | ||
Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy | Q37685285 | ||
Reaction time effects in lab- versus Web-based research: Experimental evidence | Q40349970 | ||
Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans | Q40428160 | ||
Severe acute respiratory syndrome and venous thromboembolism in multiple organs | Q48104228 | ||
Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome | Q48173180 | ||
Visual working memory as the substrate for mental rotation | Q51902867 | ||
Functional neuroanatomy of peripheral inflammatory physiology: A meta-analysis of human neuroimaging studies | Q57174266 | ||
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status | Q90310442 | ||
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy | Q90706584 | ||
COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features | Q90758823 | ||
Effect of tonsillectomy on humeral and cellular immunity: a systematic review of published studies from 2009 to 2019 | Q91002164 | ||
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? | Q91562246 | ||
A first Case of Meningitis/Encephalitis associated with SARS-Coronavirus-2 | Q91598863 | ||
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China | Q91802849 | ||
Incidence of thrombotic complications in critically ill ICU patients with COVID-19 | Q91931008 | ||
Neurologic Features in Severe SARS-CoV-2 Infection | Q91957408 | ||
Neurological Insights of COVID-19 Pandemic | Q93148984 | ||
Chest CT findings of COVID-19 pneumonia by duration of symptoms | Q93182165 | ||
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young | Q93339359 | ||
Guillain-Barré syndrome related to COVID-19 infection | Q94461259 | ||
Characteristics of ischaemic stroke associated with COVID-19 | Q94472997 | ||
Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection | Q94562977 | ||
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study | Q94571070 | ||
Neurological Manifestations of COVID-19: A review | Q94929846 | ||
Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia | Q95941765 | ||
Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry | Q96124721 | ||
EEG findings in acutely ill patients investigated for SARS-CoV-2/COVID-19: A small case series preliminary report | Q96347204 | ||
Orbitofrontal involvement in a neuroCOVID-19 patient | Q96693325 | ||
The cytokine storm of COVID-19: a spotlight on prevention and protection | Q96773475 | ||
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study | Q96949704 | ||
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020 | Q98169734 | ||
Characterization of the Cytokine Storm Reflects Hyperinflammatory Endothelial Dysfunction in COVID-19 | Q99399973 | ||
Multiple Neuroinvasive Pathways in COVID-19 | Q100379661 | ||
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series | Q100500893 | ||
Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy | Q100724061 | ||
Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment | Q101040898 | ||
COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management | Q102066142 | ||
How and why patients made Long Covid | Q102074354 | ||
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings | Q104104993 | ||
P921 | main subject | long covid | Q100732653 |
P577 | publication date | 2022-03-17 | |
P1433 | published in | Frontiers in Aging Neuroscience | Q21968084 |
P1476 | title | COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study | |
P478 | volume | 14 |
Q128786521 | An Exploratory Analysis of Contributors to Cognitive Functioning Among Sexual and Gender Minority Individuals Who Had COVID-19 |
Q114674069 | COVID-19 vaccination may enhance hippocampal neurogenesis in adults |
Q131605403 | Cognition and Memory after Covid-19 in a Large Community Sample |
Q130491900 | Immunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 Conditions |
Q129705180 | Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19 |
Q131605696 | The Effects of SARS-CoV-2 Infection on the Cognitive Functioning of Patients with Pre-Existing Dementia |
Q118118160 | The New Coronavirus Infection (COVID-19) and Hearing Function in Adults |
Search more.